All canine diagnoses

Your dog was diagnosed with Cutaneous / Digital Squamous Cell Carcinoma. Two distinct presentations: UV-induced cutaneous SCC (ventral abdomen, light-skinned breeds) and subungual/digital SCC (dark-coated large breeds). Digital SCC is the most common digital tumour in dogs. Metastatic rate varies: cutaneous ~20%, digital ~15-30% (higher for multiple digit involvement). Compare 3 treatment options for dogs including Digit Amputation (Digital SCC), Wide Surgical Excision (Cutaneous SCC), Radiation Therapy (Incomplete Excision or Inoperable) — with survival times, costs, and what to expect during treatment.

🐕

Cutaneous / Digital Squamous Cell Carcinoma

BreedsLabrador Retriever (digital)Standard Schnauzer (digital)Giant Schnauzer (digital)Rottweiler (digital)Standard Poodle (digital)Dalmatian (cutaneous UV)Bull Terrier (cutaneous UV)Whippet (cutaneous UV)
canine

Epithelial

About This Cancer

Squamous cell carcinoma of the skin and digits presents in two distinct forms with different causes and behaviours. The cutaneous (skin) form is typically caused by chronic ultraviolet radiation damage and develops on the thinly haired, lightly pigmented ventral abdomen — similar to sun-induced skin cancer in humans. The digital (toe) form, called subungual SCC, develops beneath the nail bed and is the most common tumour of the digit in dogs. Intriguingly, the digital form disproportionately affects dark-coated large breeds such as Labrador Retrievers and Standard Schnauzers, suggesting a genetic rather than environmental cause. Digital SCC typically presents as swelling of a toe, often with loss of the nail, and can mimic a simple nail bed infection. Both forms generally carry a reasonable prognosis with appropriate surgical treatment, though dogs with multiple digits affected simultaneously have a more guarded outlook.

No formal staging system widely adopted for cutaneous/digital SCC

Clinically staged by tumour size, depth of invasion, lymph node status, and distant metastasis

Stage LocalTumour confined to skin/digit without LN involvement
Stage RegionalRegional lymph node metastasis
Stage DistantDistant metastasis (lungs, other sites)
Prognostic Factors(3)
Location (cutaneous vs digital)Digital SCC with P3 lysis: good prognosis with amputation (MST 12-24 months). Cutaneous SCC: prognosis depends on depth and location.
Multiple digit involvementDogs with >1 digit affected have higher metastatic rates and worse prognosis. Screen all digits.(Schultheiss et al., 2007)
Depth of invasionSuperficial/in situ SCC has excellent prognosis with excision. Deeply invasive tumours carry higher metastatic risk.
Minimum Workup(6 steps)
1Biopsy of lesion (incisional or excisional depending on location)
2Digital radiographs (osteolysis of P3 — hallmark of digital SCC)
3Regional lymph node FNA
4Thoracic radiographs (3-view)
5Complete blood count and biochemistry
6Assessment of other digits (digital SCC can be multicentric in predisposed breeds)

Median Survival Time Comparison

How long the average patient survives with each treatment

Bar opacity reflects evidence strength
Digit Amputation (Digital SCC)
~12 mo (10–24)
Wide Surgical Excision (Cutaneous SCC)
~24 mo
Radiation Therapy (Incomplete Excision or Inoperable)
~14 mo (8–24)
Reading this page: MST (Median Survival Time) is how long the average patient survives with a given treatment. ORR (Overall Response Rate) is the percentage of patients whose tumour shrank or disappeared. CR = Complete Response (tumour gone); PR = Partial Response (tumour shrank). Hover over any abbreviation for a quick explanation.
Strength of Evidence

Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.

StrongLarge published studies with strong agreement among veterinary oncologists.
ModerateWidely used in clinical practice, but supported by smaller or retrospective studies.
IndirectEvidence comes from a different tumour type or species and has been applied here.
LimitedVery little published data is available for this specific treatment.

Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.